rp 48740 has been researched along with zidovudine in 1 studies
| Studies (rp 48740) | Trials (rp 48740) | Recent Studies (post-2010) (rp 48740) | Studies (zidovudine) | Trials (zidovudine) | Recent Studies (post-2010) (zidovudine) |
|---|---|---|---|---|---|
| 24 | 0 | 0 | 10,180 | 1,399 | 1,188 |
| Protein | Taxonomy | rp 48740 (IC50) | zidovudine (IC50) |
|---|---|---|---|
| Thymidine kinase, cytosolic | Homo sapiens (human) | 3 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.6633 | |
| Protease | Human immunodeficiency virus 1 | 0.015 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clayette, P; Dereuddre-Bosquet, N; Dormont, D; Fretier, P; Martin, M | 1 |
1 other study(ies) available for rp 48740 and zidovudine
| Article | Year |
|---|---|
Effects of RP 55778, a tumor necrosis factor alpha synthesis inhibitor, on antiviral activity of dideoxynucleosides.
Topics: Anti-HIV Agents; Dideoxynucleosides; HIV-1; Humans; Microbial Sensitivity Tests; Pyridines; Thiazoles; Tumor Necrosis Factor-alpha; Virus Replication; Zidovudine | 1997 |